Evidence map›Paper›PMID 35881319›Full record

ReviewCurrent cardiology reports2022

Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity.

Lucía Cobarro Gálvez, Emilio Arbas Redondo, Cristina Contreras Lorenzo, Teresa López Fernández

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lucía Cobarro GálvezCardiology Department, La Paz University Hospital, Paseo de La Castellana, 261, 28046, Madrid, Spain. luciacobarro@hotmail.com.ORCID http://orcid.org/0000-0003-3892-6338
Emilio Arbas RedondoCardiology Department, La Paz University Hospital, Paseo de La Castellana, 261, 28046, Madrid, Spain.
Cristina Contreras LorenzoCardiology Department, La Paz University Hospital, Paseo de La Castellana, 261, 28046, Madrid, Spain.
Teresa López FernándezCardio-Oncology Unit, La Paz University Hospital, Paseo de La Castellana, Cardiology Department, 261, 28046, Madrid, Spain.
Hospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewImplementation of advanced echocardiographic techniques in cardio-oncology is a growing need as they are the cornerstone of early detection of cancer therapy-related cardiovascular toxicity (CTR-CVT). RECENT

findingsThree-dimensional echocardiography and myocardial deformation techniques have shown more accuracy and reproducibility than classic 2D measurements in detecting cardiovascular adverse effects in patients undergoing anticancer therapies. Application of advanced echo techniques to daily monitoring of patients with cancer helps to identify those at risk of developing CTR-CVT during and after cancer treatment. Furthermore, advanced echo parameters improve early initiation of cardioprotective treatments in order to minimize cardiovascular events and cancer treatment interruption.

Indexed as

Antineoplastic AgentsNeoplasmsCardiotoxicityEarly Detection of CancerEchocardiographyHumansReproducibility of ResultsAntineoplastic Agents3D-LVEFAdvanced echocardiographic techniquesCardio-oncologyCardiotoxicityCTRCDGLSStrain

Identifiers

PMID35881319
OpenAlexW4287981450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.